Phone: (011) 7541-421, 3409-301, 3409-335, 6547-293, 3409-310
E-mail: Standards sales: prodaja@iss.rs Education: iss-edukacija@iss.rs Information about standards: infocentar@iss.rs
Stevana Brakusa 2, 11030 Beograd
Main menu

ISO 10993-6:2026

Biological evaluation of medical devices — Part 6: Tests for local effects after implantation

Apr 15, 2026

General information

60.60     Apr 15, 2026

ISO

ISO/TC 194

International Standard

11.100.20  

English   French  

Buying

Published

Language in which you want to receive the document.

Scope

This document specifies requirements for implantation test methods for preclinical assessment of the local effects after implantation of medical devices or materials intended for use in medical devices. This document is applicable to the evaluation of local tissue responses from medical devices that are intended to be used where skin or mucosal tissue is breached, when required.
This document is applicable to medical device or materials that require implantation evaluation and can be solid or non-solid (such as porous materials, liquids, gels, pastes, powders, and particulates), absorbable, degradable, non- absorbable, or can be tissue-engineered medical products (TEMPs).
These implantation tests are not intended to evaluate or determine the performance of the test sample in terms of mechanical loading or functional performance. This document also does not provide guidance on methods and study design to satisfy requirements for systemic toxicity, carcinogenicity, teratogenicity or mutagenicity. However, the study designs can be modified to also assess other biological effects.

Life cycle

PREVIOUSLY

WITHDRAWN
ISO 10993-6:2016

NOW

PUBLISHED
ISO 10993-6:2026
60.60 Standard published
Apr 15, 2026

National adoptions

Biological evaluation of medical devices - Part 6: Tests for local effects after implantation (ISO/FDIS 10993-6:2025)

50.60   Close of voting. Proof returned by secretariat

Z076 more